Neurological soft signs in familial and sporadic schizophrenia

@article{Fountoulakis2019NeurologicalSS,
  title={Neurological soft signs in familial and sporadic schizophrenia},
  author={K. Fountoulakis and P. Panagiotidis and V. Kimiskidis and I. Nimatoudis and X. Gonda},
  journal={Psychiatry Research},
  year={2019},
  volume={272},
  pages={222-229}
}
OBJECTIVE Neurological soft signs (NSS) are a group of minor non-localizable neurological abnormalities found more often in patients with schizophrenia. The aim of the current study was investigate whether there is any difference in their manifestation in familial vs. sporadic schizophrenia. MATERIAL AND METHODS The study sample included 120 patients suffering from schizophrenia according to DSM-5 (71 males and 49 females; aged 32.79 ± 11.11 years old) and 110 normal controls (57 males and 53… Expand
12-Month stability of neurological soft signs in stabilized patients with schizophrenia
TLDR
The results of the current study suggest that after stabilization of patients with schizophrenia, there are probably two separate components, a ’trait’ which is stable over a 12-month period, and a ‘degenerative’ component with a tendency to worsen probably in parallel with the progression of the illness and in correlation with the worsening of negative symptoms. Expand
Detection of Morphological Abnormalities in Schizophrenia: An Important Step to Identify Associated Genetic Disorders or Etiologic Subtypes
Current research suggests that alterations in neurodevelopmental processes, involving gene X environment interactions during key stages of brain development (prenatal period and adolescence), are aExpand
One-year Outcome of First vs. Later Episode Schizophrenia: A Real-world Naturalistic Study
TLDR
Very low rates of remission and recovery of patients with schizophrenia without any differences between FES and non-FES patients are reported, suggesting that early lack of remission is not prognostic of a poor outcome. Expand
The effect of baseline antipsychotic status on the 12‐month outcome in initially stabilized patients with schizophrenia
TLDR
The aim of the study was to measure the real‐life effect of antipsychotic treatment on remission and recovery rates in already stabilized patients with schizophrenia after 1 year. Expand

References

SHOWING 1-10 OF 93 REFERENCES
Neurological soft signs significantly differentiate schizophrenia patients from healthy controls
TLDR
It is suggested that NSS constitute an independent (from the rest of symptoms), core (present in the vast majority of patients) and trait (unrelated to age and probably to the stage of schizophrenia) symptom of schizophrenia which could be of value in the clinical assessment and research of schizophrenia. Expand
Neurological soft signs in non-psychotic first-degree relatives of patients with schizophrenia: A systematic review and meta-analysis
TLDR
There are large group differences in NSS prevalence between patients with schizophrenia, non-psychotic relatives, and healthy controls, consistent with the argument that NSS are familial in nature, segregate with the illness and may be valid and useful endophenotypes. Expand
Neurological Soft Signs in the Clinical Course of Schizophrenia: Results of a Meta-Analysis
TLDR
From a clinical perspective, NSS may be used to identify subjects at risk to develop schizophrenia and to monitor disease progression and NSS scores did not decrease to the level typically observed in healthy controls. Expand
Relative risk of neurological signs in siblings of patients with schizophrenia.
TLDR
These data suggest that neurological signs cluster in patients with schizophrenia and their families and could possibly identify a unique component of genetic variance for risk of schizophrenia, however, the fairly low relative risk and the uncertain pathophysiology of such signs may limit their usefulness. Expand
Neurological soft signs might be endophenotype candidates for patients with deficit syndrome schizophrenia
TLDR
This study confirms that NSS were higher in patients with DS, and suggests that large sampled, multicentric studies are needed to clarify the place of NSS as an endophenotype in DS. Expand
Neurological soft signs in first-episode schizophrenia: a follow-up study.
TLDR
Although neurological soft signs are intrinsic to schizophrenia, their level varies with the clinical course, and may be considered as potential predictors of outcome. Expand
A systematic review and meta-analysis of neurological soft signs in relatives of people with schizophrenia
TLDR
Both hypotheses were confirmed, suggesting that the distribution of neurological soft signs in people with schizophrenia and their first-degree relatives is consistent with the endophenotype criterion of familial association. Expand
Validation and factorial structure of a standardized neurological examination assessing neurological soft signs in schizophrenia
TLDR
A new standardized examination integrating the assessment of 23 NSS selected from the literature and the rating of well-validated scales for Assessment of extra-pyramidal symptoms confirmed a factorial structure in agreement with the conceptual areas of interest explored by NSS and should be a useful tool for assessment of the different dimensions of neurological dysfunction in schizophrenia. Expand
Neurological soft signs and minor physical anomalies in patients with schizophrenia and related disorders, their first-degree biological relatives, and non-psychiatric controls
TLDR
It is suggested that NSS and MPAs represent two quite distinct markers of risk for schizophrenia that may stem from genetic factors, as well as from environmental/developmental influences. Expand
Neurological and morphological anomalies and the genetic liability to schizophrenia: a composite phenotype
BACKGROUND Neurological soft signs (NSS) and minor physical anomalies (MPA) are frequent in patients with schizophrenia and their biological relatives. We examined whether the NSS and MPA are relatedExpand
...
1
2
3
4
5
...